D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 77 Citations 30,226 393 World Ranking 11024 National Ranking 5886

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Disease
  • Cancer

Her scientific interests lie mostly in Inflammatory bowel disease, Immunology, Internal medicine, Crohn's disease and Ulcerative colitis. Her study on Inflammatory bowel disease is covered under Disease. Marla Dubinsky has included themes like Genetics and Genome-wide association study, Single-nucleotide polymorphism in her Immunology study.

Her Internal medicine research is multidisciplinary, relying on both Gastroenterology, Surgery and Pathology. Her Crohn's disease research includes themes of Adalimumab, Clinical trial, Infliximab, Hazard ratio and Severity of illness. Her biological study spans a wide range of topics, including Maintenance therapy, NOD2, Biomarker, Physical therapy and Pediatrics.

Her most cited work include:

  • Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease (3117 citations)
  • Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci (2035 citations)
  • Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. (1061 citations)

What are the main themes of her work throughout her whole career to date?

Marla Dubinsky spends much of her time researching Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Gastroenterology and Crohn's disease. Marla Dubinsky works mostly in the field of Internal medicine, limiting it down to topics relating to Surgery and, in certain cases, Ileal Pouch Anal Anastomosis, as a part of the same area of interest. She interconnects Pregnancy, Serology, Immunology and Intensive care medicine in the investigation of issues within Inflammatory bowel disease.

The various areas that she examines in her Immunology study include Microbiome and Genome-wide association study. Her Ulcerative colitis study combines topics from a wide range of disciplines, such as Pouch, Tofacitinib, Colitis and Family medicine. Her Crohn's disease study deals with the bigger picture of Disease.

She most often published in these fields:

  • Internal medicine (50.00%)
  • Inflammatory bowel disease (41.31%)
  • Ulcerative colitis (30.82%)

What were the highlights of her more recent work (between 2019-2021)?

  • Internal medicine (50.00%)
  • Inflammatory bowel disease (41.31%)
  • Ulcerative colitis (30.82%)

In recent papers she was focusing on the following fields of study:

Marla Dubinsky focuses on Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Crohn's disease and Gastroenterology. Her study in the fields of Colectomy, Vedolizumab, Cohort and Pouchitis under the domain of Internal medicine overlaps with other disciplines such as In patient. Her Inflammatory bowel disease study contributes to a more complete understanding of Disease.

Marla Dubinsky has researched Ulcerative colitis in several fields, including Tofacitinib, Defecation, Quality of life, Bowel urgency and Adult patients. Her study in Crohn's disease is interdisciplinary in nature, drawing from both Irritable bowel syndrome, Disease management, Therapeutic drug monitoring and Hazard ratio. Marla Dubinsky interconnects Infliximab, Ileal Pouch Anal Anastomosis, Gene signature, Calprotectin and Serology in the investigation of issues within Gastroenterology.

Between 2019 and 2021, her most popular works were:

  • Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. (94 citations)
  • Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated With Infliximab. (56 citations)
  • Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice. (40 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cancer

Marla Dubinsky mostly deals with Inflammatory bowel disease, Internal medicine, Crohn's disease, Ulcerative colitis and Disease. Her studies deal with areas such as Tumor necrosis factor alpha, Multiplex, Colitis, Incidence and Etiology as well as Inflammatory bowel disease. Her Internal medicine research incorporates themes from Gastroenterology and Gene expression.

The concepts of her Crohn's disease study are interwoven with issues in Odds ratio, Pregnancy, Intensive care medicine and Hazard ratio. In the subject of general Ulcerative colitis, her work in Colectomy is often linked to Colorectal surgery, thereby combining diverse domains of study. Disease and Immunology are frequently intertwined in her study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Luke Jostins;Stephan Ripke;Rinse K Weersma;Richard H Duerr.
Nature (2012)

3671 Citations

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Andre Franke;Dermot P B McGovern;Jeffrey C. Barrett;Kai Wang.
Nature Genetics (2010)

2549 Citations

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

Carl A. Anderson;Gabrielle Boucher;Charlie W. Lees;Andre Franke.
Nature Genetics (2011)

1359 Citations

Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.

Arie Levine;Anne Griffiths;James Markowitz;David C Wilson.
Inflammatory Bowel Diseases (2011)

1287 Citations

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch.
The American Journal of Gastroenterology (2015)

1122 Citations

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

Marla C. Dubinsky;Stéphanie Lamothe;Hui Ying Yang;Stephan R. Targan.
Gastroenterology (2000)

1084 Citations

Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis

Iliyan D Iliev;Vincent A Funari;Vincent A Funari;Kent D Taylor;Quoclinh Nguyen.
Science (2012)

789 Citations

Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease.

Manuel A. Rivas;Manuel A. Rivas;Manuel A. Rivas;Mélissa Beaudoin;Agnes Gardet;Christine Stevens.
Nature Genetics (2011)

737 Citations

Genome-wide association identifies multiple ulcerative colitis susceptibility loci

Dermot P.B. McGovern;Agnès Gardet;Leif Törkvist;Philippe Goyette.
Nature Genetics (2010)

676 Citations

Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study

Isabelle Cleynen;Isabelle Cleynen;Gabrielle Boucher;Luke Jostins;Luke Jostins;Luke Jostins;L Philip Schumm.
The Lancet (2016)

544 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Marla Dubinsky

Laurent Peyrin-Biroulet

Laurent Peyrin-Biroulet

University of Lorraine

Publications: 195

Severine Vermeire

Severine Vermeire

KU Leuven

Publications: 194

Ramnik J. Xavier

Ramnik J. Xavier

Broad Institute

Publications: 170

Jean-Frederic Colombel

Jean-Frederic Colombel

Icahn School of Medicine at Mount Sinai

Publications: 168

William J. Sandborn

William J. Sandborn

University of California, San Diego

Publications: 148

Mark J. Daly

Mark J. Daly

University of Helsinki

Publications: 124

Silvio Danese

Silvio Danese

Humanitas University

Publications: 122

Anne M. Griffiths

Anne M. Griffiths

University of Toronto

Publications: 120

Dermot P.B. McGovern

Dermot P.B. McGovern

Cedars-Sinai Medical Center

Publications: 118

Andre Franke

Andre Franke

Kiel University

Publications: 110

Stefan Schreiber

Stefan Schreiber

Kiel University

Publications: 103

Hakon Hakonarson

Hakon Hakonarson

Children's Hospital of Philadelphia

Publications: 102

Mark S. Silverberg

Mark S. Silverberg

University of Toronto

Publications: 96

Gerhard Rogler

Gerhard Rogler

University of Zurich

Publications: 96

Ashwin N. Ananthakrishnan

Ashwin N. Ananthakrishnan

Harvard University

Publications: 95

Subra Kugathasan

Subra Kugathasan

Emory University

Publications: 86

Trending Scientists

Forrest Shull

Forrest Shull

Carnegie Mellon University

Roni Michaely

Roni Michaely

University of Hong Kong

Josep Pou

Josep Pou

Nanyang Technological University

Donna G. Blackmond

Donna G. Blackmond

Scripps Health

Dennis C. Liotta

Dennis C. Liotta

Emory University

Gustavo D. Aguirre

Gustavo D. Aguirre

University of Pennsylvania

Carol Soderlund

Carol Soderlund

University of Arizona

Xing Yuan

Xing Yuan

Nanjing University of Information Science and Technology

Giuseppe Piccioni

Giuseppe Piccioni

National Institute for Astrophysics

Heidrun Potschka

Heidrun Potschka

Ludwig-Maximilians-Universität München

Karine Breckpot

Karine Breckpot

Vrije Universiteit Brussel

Christopher L. King

Christopher L. King

Case Western Reserve University

Stephen H. Caldwell

Stephen H. Caldwell

University of Virginia

Otto C. Boerman

Otto C. Boerman

Radboud University Nijmegen

Emanuel A. Schegloff

Emanuel A. Schegloff

University of California, Los Angeles

Something went wrong. Please try again later.